Skip to main content

Trevena Inc(TRVN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Trevena Reports Third Quarter 2021 Results

Globe Newswire - Mon Nov 15, 2021


--

Advanced OLINVYK commercial launch with expanded field medical team and additional target markets

Announced new OLINVYK cognitive function study vs. IV morphine, enrollment expected to start in Q1 2022

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe